AIDS Vaccines
/ immunology
Apoptosis
/ drug effects
CD8-Positive T-Lymphocytes
/ drug effects
Depsipeptides
/ pharmacology
Follow-Up Studies
HIV Infections
/ drug therapy
HIV-1
Histone Code
Histone Deacetylase Inhibitors
/ pharmacology
Humans
Immunization, Secondary
Immunogenicity, Vaccine
Immunologic Memory
Lymphocyte Activation
/ drug effects
Programmed Cell Death 1 Receptor
/ biosynthesis
Proof of Concept Study
RNA, Viral
/ genetics
Virus Latency
/ drug effects
Virus Replication
HDAC inhibitor
kick&kill strategy
latency reversing agent (LRA)
romidepsin
therapeutic vaccine
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2020
2020
Historique:
received:
08
12
2019
accepted:
24
02
2020
entrez:
9
4
2020
pubmed:
9
4
2020
medline:
9
3
2021
Statut:
epublish
Résumé
Romidepsin (RMD) is a well-characterized histone deacetylase inhibitor approved for the treatment of cutaneous T-cell lymphoma.
Identifiants
pubmed: 32265913
doi: 10.3389/fimmu.2020.00418
pmc: PMC7100631
doi:
Substances chimiques
AIDS Vaccines
0
Depsipeptides
0
Histone Deacetylase Inhibitors
0
PDCD1 protein, human
0
Programmed Cell Death 1 Receptor
0
RNA, Viral
0
romidepsin
CX3T89XQBK
Types de publication
Clinical Trial, Phase I
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
418Subventions
Organisme : Medical Research Council
ID : G1001757
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N023668/1
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : P01 AI131568
Pays : United States
Organisme : Medical Research Council
ID : G0701669
Pays : United Kingdom
Investigateurs
Susana Benet
(S)
Christian Brander
(C)
Samandhy Cedeño
(S)
Bonaventura Clotet
(B)
Pep Coll
(P)
Anuksa Llano
(A)
Javier Martinez-Picado
(J)
Marta Marszalek
(M)
Sara Morón-López
(S)
Beatriz Mothe
(B)
Roger Paredes
(R)
Maria C Puertas
(MC)
Miriam Rosás-Umbert
(M)
Marta Ruiz-Riol
(M)
Roser Escrig
(R)
Silvia Gel
(S)
Miriam López
(M)
Cristina Miranda
(C)
José Moltó
(J)
Jose Muñoz
(J)
Nuria Perez-Alvarez
(N)
Jordi Puig
(J)
Boris Revollo
(B)
Jessica Toro
(J)
Ana Maria Barriocanal
(AM)
Magi Farré
(M)
Cristina Perez-Reche
(C)
Marta Valle
(M)
Christian Manzardo
(C)
Juan Ambrosioni
(J)
Irene Ruiz
(I)
Cristina Rovira
(C)
Jose M Miro
(JM)
Antonio Carrillo
(A)
Michael Meulbroek
(M)
Ferran Pujol
(F)
Jorge Saz
(J)
Nicola Borthwick
(N)
Alison Crook
(A)
Edmund G Wee
(EG)
Tomáš Hanke
(T)
Informations de copyright
Copyright © 2020 Rosás-Umbert, Ruiz-Riol, Fernández, Marszalek, Coll, Manzardo, Cedeño, Miró, Clotet, Hanke, Moltó, Mothe, Brander and the BCN02 study group.
Références
N Engl J Med. 2014 Mar 6;370(10):901-10
pubmed: 24597865
Lancet HIV. 2014 Oct;1(1):e13-21
pubmed: 26423811
Hum Vaccin Immunother. 2013 May;9(5):993-1001
pubmed: 23370291
PLoS Pathog. 2014 Apr 10;10(4):e1004071
pubmed: 24722454
J Int AIDS Soc. 2017 May 19;20(1):21171
pubmed: 28537062
J Infect Dis. 2010 Sep 1;202(5):705-16
pubmed: 20662716
Nature. 2012 Jul 25;487(7408):482-5
pubmed: 22837004
J Infect. 2017 Dec;75(6):555-571
pubmed: 28917661
Front Immunol. 2016 Sep 21;7:356
pubmed: 27708642
Sci Rep. 2016 Aug 02;6:30749
pubmed: 27480951
J Infect Dis. 2012 Aug 15;206(4):552-61
pubmed: 22711904
Blood. 2016 May 26;127(21):2546-52
pubmed: 27053530
J Infect Dis. 2015 Jul 15;212(2):258-63
pubmed: 25589335
AIDS. 2008 Jul 11;22(11):1313-22
pubmed: 18580611
PLoS Pathog. 2014 Aug 14;10(8):e1004287
pubmed: 25122219
Immunity. 2008 Dec 19;29(6):1009-21
pubmed: 19062316
Cytometry A. 2011 Feb;79(2):167-74
pubmed: 21265010
Immunotherapy. 2019 Aug;11(11):931-935
pubmed: 31218904
Front Immunol. 2018 Oct 23;9:2443
pubmed: 30405632
Sci Transl Med. 2013 Jan 2;5(166):166ra2
pubmed: 23283367
Immunity. 2012 Mar 23;36(3):491-501
pubmed: 22406268
Lancet HIV. 2016 Oct;3(10):e463-72
pubmed: 27658863
PLoS Pathog. 2016 Aug 16;12(8):e1005782
pubmed: 27529554
J Infect Dis. 2015 Mar 15;211(6):936-46
pubmed: 25249264
EClinicalMedicine. 2019 Jun 05;11:65-80
pubmed: 31312806
Antivir Ther. 2012;17(2):355-64
pubmed: 22290239
J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):229-35
pubmed: 22083073
Sci Transl Med. 2017 Dec 6;9(419):
pubmed: 29212716
PLoS Pathog. 2015 Sep 17;11(9):e1005142
pubmed: 26379282
PLoS Pathog. 2016 Apr 15;12(4):e1005545
pubmed: 27082643
PLoS Pathog. 2014 Nov 13;10(10):e1004473
pubmed: 25393648
PLoS One. 2015 Nov 06;10(11):e0141456
pubmed: 26544853
N Engl J Med. 2006 Nov 30;355(22):2283-96
pubmed: 17135583
J Virol. 2010 Oct;84(20):10543-57
pubmed: 20686036
Am J Transl Res. 2011;3(5):454-67
pubmed: 22046487
Pharmacol Res. 2019 Jan;139:524-534
pubmed: 30366100
Sci Transl Med. 2015 Dec 23;7(319):319ra206
pubmed: 26702094
J Virol. 2019 Feb 5;93(4):
pubmed: 30487276
EBioMedicine. 2017 Feb;16:141-149
pubmed: 28159573
Leuk Lymphoma. 2013 Feb;54(2):284-9
pubmed: 22839723
Nat Med. 2010 Apr;16(4):460-5
pubmed: 20228817
J Infect Dis. 2014 Sep 1;210(5):728-35
pubmed: 24620025
AIDS. 2012 Sep 24;26(15):1885-94
pubmed: 22992577
PLoS One. 2011;6(12):e27864
pubmed: 22174752